we conducted a double-blind , placebo-controlled study to evaluate the efficacy and tolerability of transdermal scopolamine in the prevention of motion sickness ( ms ) aboard a frigate during 7 days of continuously moderate or heavy seas .
C0036442
scopolamine
C0026603
motion sickness